Wednesday, March 29, 2023


Biotechnology News Magazine

TAU Systems Signs an Agreement with The University of Texas at Austin

Latest Posts

Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer

ACTO advises Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning culture could eliminate this behavior.

Entrinsic Bioscience® Expands enterade® Brand with Innovative Approach to the Dietary Support of Irritable Bowel Syndrome with Diarrhea (IBS-D

enterade® IBS-D is the first medical food formulated with plant-based amino acids and electrolytes for Irritable Bowel Syndrome with Diarrhea (IBS-D)-

Russell Finex Helps Leading Pharmaceutical Company Meet High Levels Of Demand With The Russell Compact Sieve

To ensure the highest quality final product, the company reached out to Russell Finex for a high-capacity vibrating screen. After assessing the company’s requirements, Russell Finex recommended the Russell Compact Sieve® as the ideal solution for check-screening pharmaceutical powders due to its stainless-steel contact parts, and easy-to-clean strip down design.

How Biotech Businesses Can Benefit from Freelance Experts

Ashmita Das, CEO of open talent platform Kolabtree, shares some of Kolabtree freelancer’s success stories.

TAU Systems, a producer of ultrafast, compact plasma accelerators, today announced the signing of a suite of crucial agreements with The University of Texas at Austin (UT Austin) to focus on the fundamental elements of laser-plasma interactions, advancing the science and technology of compact accelerator systems and advanced light sources, with the goal of making these tools widely available to a broad range of end-users and industry.

TAU Systems is developing the world’s first compact particle accelerators and specialized X-ray free-electron lasers that combine the capabilities of large accelerators with a small footprint to provide easy and affordable beam-time access for any company or research institute. Led by experts in laser-driven particle accelerators, TAU is democratizing accelerator access for the progress of biotechnology, nuclear and battery technology, and more.

These agreements included a Sponsored Research Agreement and a Patent License Agreement. The Sponsored Research Agreement enables TAU Systems and UT Austin personnel to work together in laboratories and collaborate on researching the fundamental elements of laser-plasma interaction. TAU will fund UT Austin laboratory staff in exchange for shared access to UT Austin laboratories, including TAU personnel working in the capacity of UT Austin research affiliates.

The Patent License Agreement establishes an exclusive license to a foundational patent on laser-plasma interaction for particle acceleration. As part of the agreement, UT Austin has been issued shares in TAU Systems.

“Thanks to our Sponsored Research Agreement, we will begin utilizing the state of the art UT Austin Tabletop Terawatt Laboratory laser, which enables our team to further explore the fundamental elements of laser-plasma interaction, a key part of our compact plasma accelerators,” said Bjorn Manuel Hegelich, TAU Systems CEO. “We have also signed a Patent License Agreement with UT Austin that grants us an exclusive license to a foundational patent on laser-plasma interaction for particle acceleration.”

Christine Dixon Thiesing, associate vice president for Discovery to Impact at UT Austin said, “This collaboration with TAU Systems highlights how the impact of academic research can be greatly amplified through startups. UT Austin is committed to supporting businesses like TAU Systems in their efforts to bring products and services to the market that change the world.”

This announcement further expands TAU Systems’ network with the world’s leading academic institutes and builds on the recently announced partnership with Lawrence Berkeley National Laboratory to demonstrate the U.S.’s first laser-driven vacuum UltraViolet free-electron laser at the BELLA Center.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine